Factor IX-deficient plasma spiked with N9-GP behaves similarly to N9-GP post-administration clinical samples in N9-GP ELISA and FIX activity assays
Author:
Affiliation:
1. Novo Nordisk A/S; Måløv Denmark
Funder
Novo Nordisk
Publisher
Wiley
Subject
Genetics(clinical),Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12680/fullpdf
Reference20 articles.
1. Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide;Ostergaard;Blood,2011
2. Population pharmacokinetic modeling for dose setting of nonacog beta pegol (N9-GP), a glycoPEGylated recombinant factor IX;Collins;J Thromb Haemost,2012
3. Development of long-acting recombinant FVIII and FIX Fc fusion proteins for the management of hemophilia;Shapiro;Expert Opin Biol Ther,2013
4. The hope and reality of long-acting hemophilia products;Pipe;Am J Hematol,2012
5. Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B;Negrier;Blood,2011
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. High variability in Factor IX one‐stage assay in samples spiked with nonacog beta pegol among different pairs of reagent/detection system;International Journal of Laboratory Hematology;2023-09-13
2. IDELVION: A Comprehensive Review of Clinical Trial and Real-World Data;Journal of Clinical Medicine;2022-02-18
3. External quality assessment for one‐stage and chromogenic factor IX assays in samples containing Alprolix (rFIXFc) or Idelvion (rIX‐FP) and evidence that UK National External Quality Assessment Scheme for blood coagulation samples are commutable with patient samples;International Journal of Laboratory Hematology;2022-01-17
4. Laboratory measurement of factor replacement therapies in the treatment of congenital haemophilia: A United Kingdom Haemophilia Centre Doctors’ Organisation guideline;Haemophilia;2019-12-17
5. Advances in the Treatment of Hemophilia: Implications for Laboratory Testing;Clinical Chemistry;2019-02-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3